![Harry Stylli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Harry Stylli
Fondatore presso
Immunis.AI, Inc.
Profilo
Harry Stylli was the founder of Biora Therapeutics, Inc., founded in 2010, where the title held was Chairman & Chief Executive Officer from 2010 to 2021.
Dr. Stylli is also the founder of Immunis.
AI, Inc...
Current jobs include Executive Chairman at OncoCell MDx, Inc since 2019 and Director at Duke Institute For Brain Sciences.
Former jobs include President & Chief Executive Officer at Sequenom, Inc. from 2005 to 2009, President & Chief Executive Officer at Xencor, Inc. from 2004 to 2005, President & Chief Executive Officer at CovX Research LLC from 2002 to 2003, Director at Molecular Insight Pharmaceuticals, Inc. from 2004 to 2010, Director at Micropharma Ltd., President at Aurora Biosciences Corp.
from 1995 to 2002, and President at Pan Vera LLC in 1995.
Education includes a doctorate from the University of London, an MBA from The Open University, and an undergraduate degree from the University of East London.
Posizioni attive di Harry Stylli
| Società | Posizione | Inizio |
|---|---|---|
Duke Institute For Brain Sciences
 Duke Institute For Brain Sciences Miscellaneous Commercial ServicesCommercial Services The Duke Institute for Brain Sciences at Duke University is an interdisciplinary center dedicated to advancing neuroscience research, education, and community engagement. The private company is based in Durham. The institute promotes collaborative brain science across diverse disciplines and translates discoveries into health and societal solutions. It encompasses research themes such as brain health and wellness, cognition, neurotechnology, brain development and aging, cellular and molecular neuroscience, perception, emotions, social behavior, computation, hormones, immunology, movement, and intersections with art, humanities, law, policy, and business. The institute supports projects including high-resolution brain imaging, autism screening technologies, and studies on communication impairments following right-hemisphere strokes. Faculty conduct research on molecular mechanisms of social experience effects on the brain, adult neurogenic communication disorders post-stroke, and computational neuroscience. The institute provides resources for education, research collaboration, and public outreach, and offers opportunities for support and involvement. | Direttore/Membro del Consiglio | - |
OncoCell MDx, Inc
 OncoCell MDx, Inc BiotechnologyHealth Technology Engages in developing and commercializing immunogenic therapies | Presidente | 01/04/2019 |
Immunis.AI, Inc.
 Immunis.AI, Inc. Packaged SoftwareTechnology Services Develops non-invasive blood-based immunogenomic platform | Fondatore | - |
Precedenti posizioni note di Harry Stylli
| Società | Posizione | Fine |
|---|---|---|
| BIORA THERAPEUTICS, INC. | Amministratore Delegato | 01/09/2021 |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Direttore/Membro del Consiglio | 12/05/2010 |
| SEQUENOM, INC. | Amministratore Delegato | 28/09/2009 |
| XENCOR, INC. | Presidente | 01/02/2005 |
CovX Research LLC
 CovX Research LLC BiotechnologyHealth Technology Manufactures biotherapeutics and medical products | Presidente | 01/07/2003 |
Formazione di Harry Stylli
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
68
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
Aurora Biosciences Corp.
 Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
Sequenom, Inc.
 Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Health Services |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Micropharma Ltd.
 Micropharma Ltd. Pharmaceuticals: MajorHealth Technology Formulates, manufactures & sells functional food, neutraceuticals and pharmaceutical products | Health Technology |
Pan Vera LLC
 Pan Vera LLC BiotechnologyHealth Technology Develops protein drug targets and drug screening assays for high throughput screening | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Open University
 The Open University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CovX Research LLC
CovX Research LLC BiotechnologyHealth Technology Manufactures biotherapeutics and medical products | Health Technology |
University of East London
 University of East London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biora Therapeutics, Inc.
 Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
OncoCell MDx, Inc
OncoCell MDx, Inc BiotechnologyHealth Technology Engages in developing and commercializing immunogenic therapies | Health Technology |
Duke Institute For Brain Sciences
Duke Institute For Brain Sciences Miscellaneous Commercial ServicesCommercial Services The Duke Institute for Brain Sciences at Duke University is an interdisciplinary center dedicated to advancing neuroscience research, education, and community engagement. The private company is based in Durham. The institute promotes collaborative brain science across diverse disciplines and translates discoveries into health and societal solutions. It encompasses research themes such as brain health and wellness, cognition, neurotechnology, brain development and aging, cellular and molecular neuroscience, perception, emotions, social behavior, computation, hormones, immunology, movement, and intersections with art, humanities, law, policy, and business. The institute supports projects including high-resolution brain imaging, autism screening technologies, and studies on communication impairments following right-hemisphere strokes. Faculty conduct research on molecular mechanisms of social experience effects on the brain, adult neurogenic communication disorders post-stroke, and computational neuroscience. The institute provides resources for education, research collaboration, and public outreach, and offers opportunities for support and involvement. | Commercial Services |
Immunis.AI, Inc.
Immunis.AI, Inc. Packaged SoftwareTechnology Services Develops non-invasive blood-based immunogenomic platform | Technology Services |
